The actual root cause
PCOS is misnamed. Most affected women don't have "polycystic ovaries", the cysts are a downstream finding. The actual mechanism: insulin resistance drives compensatory hyperinsulinemia. High insulin signals the ovaries to produce extra androgens (testosterone, DHT). High androgens disrupt follicle maturation and ovulation. Cycles become irregular. Weight gain accelerates (insulin is a fat-storage hormone). The cycle reinforces itself.
This is why insulin sensitivity, not androgen suppression, is the right target.
Why standard treatment falls short
Standard PCOS care: birth control to "regulate cycles" and metformin for insulin. Both work, but neither addresses the loop. Birth control masks the symptom by suppressing ovulation entirely. Metformin produces 5-8% weight loss and modest insulin improvement. Most women remain symptomatic, struggle with weight, and develop type 2 diabetes risk over time.
GLP-1s as primary treatment
GLP-1 medications produce 10-20% weight loss and 30-40% improvements in insulin sensitivity. The Jensterle et al. trials of semaglutide in PCOS showed restored ovulation in 60%+, dramatic androgen reduction, and metabolic normalization within 6 months (Jensterle et al., Endocrine Connections 2020). Tirzepatide's dual GIP/GLP-1 mechanism appears to outperform semaglutide for PCOS specifically.
Inositol as adjunct
Myo-inositol + D-chiro-inositol in 40:1 ratio (typically 4 g myo + 100 mg D-chiro daily) improves ovulation and insulin sensitivity. The Unfer et al. meta-analysis of 9 RCTs showed inositol restored ovulation in 47-62% of PCOS women within 6 months (Unfer et al., Endocr Connect 2017). Cheap, safe, well-evidenced. Use as part of a stack, not as sole therapy.
Training and protein
Resistance training improves insulin sensitivity 30-40% independent of weight loss. Combined with adequate protein (1.0 g/lb of goal weight), it accelerates body composition change. The PCOS body composition pattern (apple shape, abdominal weight) responds particularly well to compound lifting paired with adequate protein.
Selective hormonal support
Some women benefit from cyclical or continuous bioidentical progesterone, see progesterone for sleep and mood. Spironolactone may be added for severe acne or hirsutism. Birth control remains useful for women not pursuing fertility but is no longer the default first-line.
Timeline of recovery
| Time | Typical changes |
|---|---|
| Month 1 | Improved appetite control on GLP-1; small weight loss |
| Month 3 | 5-8% weight loss; lower fasting insulin; improving cycles |
| Month 6 | 10-15% weight loss; ovulation returning in many; lower androgens |
| Month 12 | 15-20% weight loss; cycles regular; symptoms minimal in most |
The shift: Modern PCOS care treats it as a metabolic disease that happens to manifest in the ovaries, not an ovarian disease that happens to affect metabolism.
Bottom line
PCOS responds dramatically to root-cause treatment of insulin resistance. The combination of GLP-1, inositol, training, protein, and selective hormonal support produces outcomes that birth-control-and-metformin protocols rarely achieve. For women with PCOS still struggling on traditional treatment, modern protocols are worth a conversation.